Inge C. van Gool

2.0k total citations
13 papers, 1.3k citations indexed

About

Inge C. van Gool is a scholar working on Obstetrics and Gynecology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Inge C. van Gool has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Obstetrics and Gynecology, 7 papers in Cancer Research and 5 papers in Reproductive Medicine. Recurrent topics in Inge C. van Gool's work include Endometrial and Cervical Cancer Treatments (8 papers), Cancer Genomics and Diagnostics (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). Inge C. van Gool is often cited by papers focused on Endometrial and Cervical Cancer Treatments (8 papers), Cancer Genomics and Diagnostics (5 papers) and Ovarian cancer diagnosis and treatment (5 papers). Inge C. van Gool collaborates with scholars based in Netherlands, United Kingdom and Australia. Inge C. van Gool's co-authors include Tjalling Bosse, David N. Church, Daniëlle Cohen, Samuel B. Polak, Jan H. von der Thüsen, Judith van Paassen, Ian Tomlinson, Claire Palles, Carien L. Creutzberg and Emily Rayner and has published in prestigious journals such as Nature reviews. Cancer, Clinical Cancer Research and Oncotarget.

In The Last Decade

Inge C. van Gool

13 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge C. van Gool Netherlands 12 495 389 313 303 270 13 1.3k
Corinne Rusterholz Switzerland 18 224 0.5× 783 2.0× 215 0.7× 236 0.8× 358 1.3× 39 1.6k
Belén Perez‐Mies Spain 15 267 0.5× 210 0.5× 201 0.6× 269 0.9× 278 1.0× 61 946
Maria Sotiropoulou Greece 18 181 0.4× 221 0.6× 136 0.4× 117 0.4× 145 0.5× 113 1.0k
Seung Yeon Ha South Korea 17 300 0.6× 146 0.4× 68 0.2× 109 0.4× 143 0.5× 82 859
Amal Kanbour‐Shakir United States 21 189 0.4× 289 0.7× 163 0.5× 169 0.6× 224 0.8× 55 1.2k
M Kowalska Poland 16 448 0.9× 105 0.3× 82 0.3× 109 0.4× 231 0.9× 56 888
Carla Bartosch Portugal 17 151 0.3× 228 0.6× 88 0.3× 128 0.4× 179 0.7× 57 735
Bruno Ghiringhello Italy 21 525 1.1× 332 0.9× 125 0.4× 138 0.5× 265 1.0× 51 2.0k
S. Lasry France 14 243 0.5× 192 0.5× 185 0.6× 329 1.1× 52 0.2× 32 798
M. Burk Germany 15 209 0.4× 58 0.1× 154 0.5× 119 0.4× 131 0.5× 21 944

Countries citing papers authored by Inge C. van Gool

Since Specialization
Citations

This map shows the geographic impact of Inge C. van Gool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge C. van Gool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge C. van Gool more than expected).

Fields of papers citing papers by Inge C. van Gool

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge C. van Gool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge C. van Gool. The network helps show where Inge C. van Gool may publish in the future.

Co-authorship network of co-authors of Inge C. van Gool

This figure shows the co-authorship network connecting the top 25 collaborators of Inge C. van Gool. A scholar is included among the top collaborators of Inge C. van Gool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge C. van Gool. Inge C. van Gool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gool, Inge C. van, Jesper Kers, Jaap Bakker, et al.. (2022). Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature. Clinical Rheumatology. 41(10). 2949–2960. 15 indexed citations
2.
Polak, Samuel B., Inge C. van Gool, Daniëlle Cohen, Jan H. von der Thüsen, & Judith van Paassen. (2020). A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Modern Pathology. 33(11). 2128–2138. 312 indexed citations
3.
Workel, Hagma H., Joyce M. Lubbers, Roland Arnold, et al.. (2019). A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer. Cancer Immunology Research. 7(5). 784–796. 167 indexed citations
4.
Gool, Inge C. van, Emily Rayner, Elisabeth M. Osse, et al.. (2018). Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues. Clinical Cancer Research. 24(13). 3197–3203. 58 indexed citations
5.
Eggink, Florine A., Inge C. van Gool, Alexandra Léary, et al.. (2017). Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition. Data Archiving and Networked Services (DANS). 17 indexed citations
6.
Gool, Inge C. van, Cor D. de Kroon, Remi A. Nout, et al.. (2017). Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer. Oncotarget. 8(15). 25542–25551. 13 indexed citations
7.
Gool, Inge C. van, Ellen Stelloo, Cor D. de Kroon, et al.. (2017). Blinded histopathological characterisation of POLE exonuclease domainmutant endometrial cancers: sheep in wolf's clothing. Histopathology. 72(2). 248–258. 39 indexed citations
8.
Gool, Inge C. van, Ellen Stelloo, Remi A. Nout, et al.. (2016). Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer. Modern Pathology. 29(2). 174–181. 66 indexed citations
9.
Rayner, Emily, Inge C. van Gool, Claire Palles, et al.. (2016). A panoply of errors: polymerase proofreading domain mutations in cancer. Nature reviews. Cancer. 16(2). 71–81. 254 indexed citations
10.
Eggink, Florine A., Inge C. van Gool, Alexandra Léary, et al.. (2016). Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition. OncoImmunology. 6(2). e1264565–e1264565. 101 indexed citations
11.
Gool, Inge C. van, Florine A. Eggink, Luke Freeman-Mills, et al.. (2015). POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer. Clinical Cancer Research. 21(14). 3347–3355. 231 indexed citations
12.
Gool, Inge C. van, Ellen Stelloo, Remi A. Nout, et al.. (2015). PROGNOSTIC VALUE OF L1CAM EXPRESSION AND ITS ASSOCIATION WITH MUTANT P53 EXPRESSION IN HIGH-RISK ENDOMETRIAL CANCER PATIENTS: A TRANSPORTEC STUDY. International Journal of Gynecological Cancer. 25. 258–259. 1 indexed citations
13.
Gool, Inge C. van, Tjalling Bosse, & David N. Church. (2015). POLE proofreading mutation, immune response and prognosis in endometrial cancer. OncoImmunology. 5(3). e1072675–e1072675. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026